144 related articles for article (PubMed ID: 19824432)
21. Ki-67 expression in patients with uterine leiomyomas, uterine smooth muscle tumors of uncertain malignant potential (STUMP) and uterine leiomyosarcomas (LMS).
Mayerhofer K; Lozanov P; Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K
Acta Obstet Gynecol Scand; 2004 Nov; 83(11):1085-8. PubMed ID: 15488127
[TBL] [Abstract][Full Text] [Related]
22. Ki-67, p53 and bcl-2 analysis in colonic versus rectal adenocarcinoma.
Petrişor O; Giuşcă SE; Sajin M; Dobrescu G; Căruntu ID
Rom J Morphol Embryol; 2008; 49(2):163-71. PubMed ID: 18516322
[TBL] [Abstract][Full Text] [Related]
23. Analysis of p53, BCL-2 and epidermal growth factor receptor protein expression in the partial and complete hydatidiform moles.
Hussein MR
Exp Mol Pathol; 2009 Aug; 87(1):63-9. PubMed ID: 19348791
[TBL] [Abstract][Full Text] [Related]
24. Uterine leiomyosarcoma arising in leiomyoma: clinicopathological study of four cases and literature review.
Yanai H; Wani Y; Notohara K; Takada S; Yoshino T
Pathol Int; 2010 Jul; 60(7):506-9. PubMed ID: 20594271
[TBL] [Abstract][Full Text] [Related]
25. High levels of cellular retinol binding protein-1 expression in leiomyosarcoma: possible implications for diagnostic evaluation.
Orlandi A; Francesconi A; Clément S; Ropraz P; Spagnoli LG; Gabbiani G
Virchows Arch; 2002 Jul; 441(1):31-40. PubMed ID: 12111198
[TBL] [Abstract][Full Text] [Related]
26. [Argyrophilic proteins of nucleolar organizers regions as markers of malignancy grade of anaplastic large-cell lymphoma and Hodgkin's lymphoma].
Raĭkhlin NT; Bukaeva IA; Probatova NA; Smirnova EA; Pavlovskaia AI; Tupitsin NN; Sholokhova EN; Osmanov ShSh
Arkh Patol; 2004; 66(5):30-4. PubMed ID: 15575384
[TBL] [Abstract][Full Text] [Related]
27. Expression of molecular biological markers in breast cancer under conditions of the Sakha Republic (Yakutia).
Kirillina MP; Loskutova KS; Lushnikova EL; Nepomnyashchikh LM
Bull Exp Biol Med; 2014 Sep; 157(5):623-7. PubMed ID: 25257427
[TBL] [Abstract][Full Text] [Related]
28. [Significance of the expression of nucleolar argyrophilic proteins and antigen Ki-67 in the evaluation of cell proliferative activity and in the prediction of minimal (T1) lung cancer].
Raĭkhlin NT; Bukaeva IA; Smirnova EA; Gurevich LE; Delektorskaia VV; Polotskiĭ BE; Laktionov KK; Ardzinba Ms
Arkh Patol; 2008; 70(3):15-8. PubMed ID: 18727426
[TBL] [Abstract][Full Text] [Related]
29. Oncogenic property of acrogranin in human uterine leiomyosarcoma: direct evidence of genetic contribution in in vivo tumorigenesis.
Matsumura N; Mandai M; Miyanishi M; Fukuhara K; Baba T; Higuchi T; Kariya M; Takakura K; Fujii S
Clin Cancer Res; 2006 Mar; 12(5):1402-11. PubMed ID: 16533762
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical analysis of carcinomatous and sarcomatous components in the uterine carcinosarcoma: a case report.
Semczuk A; Skomra D; Chyzyńska M; Szewczuk W; Olcha P; Korobowicz E
Pathol Res Pract; 2008; 204(3):203-7. PubMed ID: 18207653
[TBL] [Abstract][Full Text] [Related]
31. Are there any differences in the expression of hormonal receptors and proliferation markers between uterine and extrauterine leiomyomas?
Sen N; Demirkan NC; Colakoglu N; Duzcan SE
Int J Surg Pathol; 2008 Jan; 16(1):43-7. PubMed ID: 18203783
[TBL] [Abstract][Full Text] [Related]
32. Uterine leiomyoma versus leiomyosarcoma: a new attempt at differential diagnosis based on their cellular characteristics.
Watanabe K; Suzuki T
Histopathology; 2006 Apr; 48(5):563-8. PubMed ID: 16623782
[TBL] [Abstract][Full Text] [Related]
33. The apoptotic paradox in retinoblastoma.
Sitorus RS; Gumay S; van der Valk P
Ann N Y Acad Sci; 2009 Aug; 1171():77-86. PubMed ID: 19723039
[TBL] [Abstract][Full Text] [Related]
34. Differential Immunoreactivity of p16 in leiomyosarcomas and leiomyoma variants.
Gannon BR; Manduch M; Childs TJ
Int J Gynecol Pathol; 2008 Jan; 27(1):68-73. PubMed ID: 18156978
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical study of DNA topoisomerase I, p53, and Ki-67 in uterine carcinosarcomas.
Lee SJ; Kim HS; Kim HS; Chun YK; Hong SR; Lee JH
Hum Pathol; 2007 Aug; 38(8):1226-31. PubMed ID: 17490723
[TBL] [Abstract][Full Text] [Related]
36. [Expression of bcl-2, Ki-67 and p-53 in uveal melanomas].
Krvavica A; Talan-Hranilović J; Belicza M
Acta Med Croatica; 2008 Jul; 62(3):267-71. PubMed ID: 18843846
[TBL] [Abstract][Full Text] [Related]
37. Characterization of estrogen receptors alpha and beta in uterine leiomyoma cells.
Valladares F; Frías I; Báez D; García C; López FJ; Fraser JD; Rodríguez Y; Reyes R; Díaz-Flores L; Bello AR
Fertil Steril; 2006 Dec; 86(6):1736-43. PubMed ID: 17011556
[TBL] [Abstract][Full Text] [Related]
38. Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system.
D'Angelo E; Spagnoli LG; Prat J
Hum Pathol; 2009 Nov; 40(11):1571-85. PubMed ID: 19540555
[TBL] [Abstract][Full Text] [Related]
39. Expression of B23/Nucleophosphamine Nonribosomal Nucleolar Protein in Smooth Muscle Tumors of the Corpus Uteri.
Avdalyan AM; Kobyakov DS; Klimachev VV; Bobrov IP; Lazarev AF; Pichigina AK; Lushnikova EL; Nepomnyashchikh LM
Bull Exp Biol Med; 2015 Dec; 160(2):286-90. PubMed ID: 26642792
[TBL] [Abstract][Full Text] [Related]
40. Epithelioid smooth muscle tumors of the uterus do not express CD1a: a potential immunohistochemical adjunct in their distinction from uterine perivascular epithelioid cell tumors.
Fadare O; Liang SX
Ann Diagn Pathol; 2008 Dec; 12(6):401-5. PubMed ID: 18995203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
